ClinicalTrials.gov
ClinicalTrials.gov Menu

Value of Percutaneous Cholangioscopy After Placement of a Percutaneous Transhepatic Biliary Drainage

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00942630
Recruitment Status : Completed
First Posted : July 21, 2009
Last Update Posted : October 10, 2011
Sponsor:
Information provided by (Responsible Party):
Tobias J. Weismueller, Hannover Medical School

Brief Summary:
In a prospective study the investigators perform repeated cholangioscopies in all patients that received percutaneous transhepatic biliary drainage (PTBD) for a variety of malignant and benign diseases. Endoscopic findings and their correlation with clinical features will be recorded prospectively. The impact on clinical decision will be evaluated.

Condition or disease
Bile Duct Stricture Not Treatable by ERC

Study Type : Observational
Estimated Enrollment : 40 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Percutaneous Cholangioscopy After Placement of a Percutaneous Transhepatic Biliary Drainage (PTBD) - a Prospective Study on Endoscopic Findings and Clinical Impact
Study Start Date : March 2008
Actual Primary Completion Date : December 2010
Actual Study Completion Date : April 2011




Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   1 Year and older   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
All patients receiving a PTBD
Criteria

Inclusion Criteria:

PTBD with at least 14 French in diameter

Exclusion Criteria:

missing informed consent


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00942630


Locations
Germany
Hannover Medical School
Hannover, Germany
Sponsors and Collaborators
Hannover Medical School

Responsible Party: Tobias J. Weismueller, Dr. T. Weismüller, Hannover Medical School
ClinicalTrials.gov Identifier: NCT00942630     History of Changes
Other Study ID Numbers: MHH-ENDO-0709
First Posted: July 21, 2009    Key Record Dates
Last Update Posted: October 10, 2011
Last Verified: October 2011

Keywords provided by Tobias J. Weismueller, Hannover Medical School:
percutaneous
transhepatic
biliary
drainage
cholangioscopy